Letter to the Editors: Concerning "Long-term safety and efficacy of AAV gene therapy in the canine model of glycogen storage disease type Ia" by Lee et al
- PMID: 30255460
- PMCID: PMC6501822
- DOI: 10.1007/s10545-018-0248-2
Letter to the Editors: Concerning "Long-term safety and efficacy of AAV gene therapy in the canine model of glycogen storage disease type Ia" by Lee et al
Conflict of interest statement
Conflict of Interest:
Elizabeth D. Brooks, Priya Kishnani, and Dwight D. Koeberl have no conflicts of interest to report.
Comment in
-
Response letter.J Inherit Metab Dis. 2018 Nov;41(6):915. doi: 10.1007/s10545-018-0249-1. J Inherit Metab Dis. 2018. PMID: 30264173 No abstract available.
Comment on
-
Long-term safety and efficacy of AAV gene therapy in the canine model of glycogen storage disease type Ia.J Inherit Metab Dis. 2018 Nov;41(6):977-984. doi: 10.1007/s10545-018-0199-7. Epub 2018 May 25. J Inherit Metab Dis. 2018. PMID: 29802554
References
-
- Lee YM, Conlon TJ, Specht A, et al. (2018). Long-term safety and efficacy of AAV gene therapy in the canine model of glycogen storage disease type Ia. J Inherit Metab Dis. - PubMed
Publication types
MeSH terms
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources